| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Jafron Biomedical Co.Ltd (SHE: 300529)
300529 Technical Analysis
5
| As on 9th Jun 2023 300529 STOCK Price closed @ 24.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 46.20 & Strong Sell for SHORT-TERM with Stoploss of 50.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300529STOCK Price
| Open | 26.75 | Change | Price | % |
| High | 26.85 | 1 Day | -1.90 | -7.13 |
| Low | 23.87 | 1 Week | -2.87 | -10.39 |
| Close | 24.76 | 1 Month | -4.19 | -14.47 |
| Volume | 23945194 | 1 Year | -26.27 | -51.48 |
| 52 Week High 56.12 | 52 Week Low 26.65 | ||||
SHE China Most Active Stocks
| 000100 | 3.90 | 1.04% |
| 300315 | 6.32 | 19.92% |
| 002602 | 7.57 | 10.03% |
| 300459 | 6.89 | 4.71% |
| 000725 | 4.00 | 1.78% |
| 300002 | 14.07 | 9.92% |
| 300058 | 10.87 | 1.68% |
| 002354 | 7.41 | 4.66% |
| 300059 | 14.23 | -1.59% |
| 002292 | 11.19 | -4.44% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 300529 Daily Charts |
300529 Intraday Charts |
Whats New @ Bazaartrend |
300529 Free Analysis |
|
|
300529 Important Levels Intraday
| RESISTANCE | 30.50 |
| RESISTANCE | 28.66 |
| RESISTANCE | 27.52 |
| RESISTANCE | 26.38 |
| SUPPORT | 23.14 |
| SUPPORT | 22.00 |
| SUPPORT | 20.86 |
| SUPPORT | 19.02 |
300529 Forecast May 2024
| 4th UP Forecast | 51.72 |
| 3rd UP Forecast | 43.07 |
| 2nd UP Forecast | 37.73 |
| 1st UP Forecast | 32.38 |
| 1st DOWN Forecast | 17.14 |
| 2nd DOWN Forecast | 11.79 |
| 3rd DOWN Forecast | 6.45 |
| 4th DOWN Forecast | -2.2 |
300529 Weekly Forecast
| 4th UP Forecast | 33.62 |
| 3rd UP Forecast | 30.78 |
| 2nd UP Forecast | 29.02 |
| 1st UP Forecast | 27.27 |
| 1st DOWN Forecast | 22.25 |
| 2nd DOWN Forecast | 20.50 |
| 3rd DOWN Forecast | 18.74 |
| 4th DOWN Forecast | 15.90 |
300529 Forecast2024
| 4th UP Forecast | 93.73 |
| 3rd UP Forecast | 71.61 |
| 2nd UP Forecast | 57.94 |
| 1st UP Forecast | 44.27 |
| 1st DOWN Forecast | 5.25 |
| 2nd DOWN Forecast | -8.42 |
| 3rd DOWN Forecast | -22.09 |
| 4th DOWN Forecast | -44.21 |
Jafron Biomedical Co.Ltd ( SHE China Symbol : 300529 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300529 Business Profile
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and medical adsorbable suture with needles. The company offers its products in Germany, Italy, Turkey, Thailand, Vietnam, the Philippines, South Africa, Kenya, Chile, Peru, and the United Arab Emirates. Jafron Biomedical Co.,Ltd. was founded in 1989 and is based in Zhuhai, China. Address: No. 98 Keji 6th Road, Zhuhai, China, 519085
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service